Montelukast berberine quaternary ammonium salt compound and double salt composition, and synthesis method therefor and use thereof
US12221418B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 16, 2022 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Nov 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a montelukast berberine double salt or composition with anti-inflammatory, antibacterial and immunomodulatory effects. Particularly, disclosed are a montelukast berberine quaternary ammonium salt with a structure as represented by formula (I), a double salt or a composition, a solvate, a hydrate, an isotope substitution or an isomer thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.